Attitudes Toward Proactive Topical Corticosteroid Use Among Women With Vulval Lichen Sclerosus
Copyright © 2024, ASCCP..
OBJECTIVES: Some practitioners are adopting proactive topical corticosteroid (TCS) therapy for vulval lichen sclerosus (VLS). We sought to understand patient attitudes toward proactive TCS therapy for VLS in a context in which proactive therapy is adopted.
METHODS: Four online focus group discussions with 12 participants. Data analysis was informed by social constructionist grounded theory.
RESULTS: All participants had accepted a proactive regimen. Three themes were developed from the analysis: "Coming to accept proactive therapy," "Motivators to maintaining a proactive regimen," and "The importance of a routine that fits me." Within each theme are subthemes illustrating different dimensions of the theme.
CONCLUSIONS: Accepting proactive TCS therapy for VLS requires incorporating regular TCS use into a patient's identity, unlearning previous understandings regarding the safety of long-term TCS use, and adopting a regimen that fits within patients' lives and minimizes the loss of autonomy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Journal of lower genital tract disease - 28(2024), 2 vom: 01. März, Seite 183-188 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rees, Sophie [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adrenal Cortex Hormones |
---|
Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1097/LGT.0000000000000791 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM37007789X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM37007789X | ||
003 | DE-627 | ||
005 | 20240325235533.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240324s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/LGT.0000000000000791 |2 doi | |
028 | 5 | 2 | |a pubmed24n1347.xml |
035 | |a (DE-627)NLM37007789X | ||
035 | |a (NLM)38518216 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rees, Sophie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Attitudes Toward Proactive Topical Corticosteroid Use Among Women With Vulval Lichen Sclerosus |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2024 | ||
500 | |a Date Revised 25.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024, ASCCP. | ||
520 | |a OBJECTIVES: Some practitioners are adopting proactive topical corticosteroid (TCS) therapy for vulval lichen sclerosus (VLS). We sought to understand patient attitudes toward proactive TCS therapy for VLS in a context in which proactive therapy is adopted | ||
520 | |a METHODS: Four online focus group discussions with 12 participants. Data analysis was informed by social constructionist grounded theory | ||
520 | |a RESULTS: All participants had accepted a proactive regimen. Three themes were developed from the analysis: "Coming to accept proactive therapy," "Motivators to maintaining a proactive regimen," and "The importance of a routine that fits me." Within each theme are subthemes illustrating different dimensions of the theme | ||
520 | |a CONCLUSIONS: Accepting proactive TCS therapy for VLS requires incorporating regular TCS use into a patient's identity, unlearning previous understandings regarding the safety of long-term TCS use, and adopting a regimen that fits within patients' lives and minimizes the loss of autonomy | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Glucocorticoids |2 NLM | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Dermatologic Agents |2 NLM | |
700 | 1 | |a Arnold, Susanne |e verfasserin |4 aut | |
700 | 1 | |a Kherlopian, Ashod |e verfasserin |4 aut | |
700 | 1 | |a Fischer, Gayle |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of lower genital tract disease |d 1997 |g 28(2024), 2 vom: 01. März, Seite 183-188 |w (DE-627)NLM096443464 |x 1526-0976 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2024 |g number:2 |g day:01 |g month:03 |g pages:183-188 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/LGT.0000000000000791 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2024 |e 2 |b 01 |c 03 |h 183-188 |